BioStem Technologies, Inc. (BSEM)
4.93
+0.36
(+7.95%)
USD |
OTCM |
Apr 06, 16:00
BioStem Technologies SG&A Expense (TTM) : 116.97M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Plus Therapeutics, Inc. | 12.13M |
| Iovance Biotherapeutics, Inc. | 152.58M |
| Protokinetix, Inc. | 0.063M |
| GB Sciences, Inc. | 0.9456M |
| Travere Therapeutics, Inc. | 337.20M |